Sue qualified from Cambridge in 1984 and then spent time in mixed practice in Devon before taking her Certificate and then British and European Diplomas in Veterinary Dermatology.
Sue has been an RCVS and European Specialist for more than 20 years. She has recently been elected as a Fellow of the RCVS for meritorious contributions to clinical practice, is an elected member of the RCVS Council and is the Senior Vice President of the European Society of Veterinary Dermatology.
Sue is the Veterinary Director of two companies: Veterinary Dermatological Ltd, a manufacturer of a range of veterinary dermatology supplements, and Virtual Vet Derms, a veterinary telemedicine company. She has published seven text books as well as writing numerous peer reviewed articles and contributing chapters to both small animal and equine text books. She lectures extensively in Europe and America.
During her Presidency, Sue intends to consolidate everything she believes to be great about the Association. She said: "BSAVA has just completed a three-year strategic plan and my Presidency is going to be all about driving this forward. There are so many new initiatives in the pipeline I can’t wait to get started. I am looking forward to working with my dynamic teams of BSAVA officers and our amazing Woodrow House staff to show just how great BSAVA really is."
Professor Ian Ramsey becomes Vice President.
Current World Organisation for Animal Health (OIE) recommendations are to include a representative strain from each of the two sublineages of equine influenza virus (EIV) - Florida Clade 1 and Florida Clade 2, to deliver optimum protection.
MSD's study was designed to evaluate the efficacy of Equilis Prequenza, containing whole virus Newmarket/2/93 (European strain) and South Africa/4/03 (Clade1) EIV strains, and an HA canarypox vectored vaccine containing Florida Clade 1 and Clade 2 strains.
Two groups of seven Fjord ponies were vaccinated twice, 4 weeks apart (V1 on day 0 and V2 on day 28). One group was vaccinated with Equilis Prequenza (MSD AH) and one group with ProteqFlu (Boehringer Ingleheim). The protective antibody response was measured and ponies were challenged, along with six unvaccinated control ponies, by experimental infection with Wexford/14 (a heterologous clade 2 strain), 1 20 days (4.5 months) after V2, and clinical signs and virus shedding monitored. EI serology was measured by single radial haemolysis (SRH) and hemagglutination inhibition (HI). Clinical signs and virus shedding (measured by qRT-PCR and egg titration) were compared between groups and with controls.
Vicki Farr, BVetMed MRCVS, equine veterinary advisor at MSD Animal Health said: "Following challenge at 120 days after V2 with Wexford/14, this study demonstrates that both vaccines provide a highly significant degree of protection against clinical signs of EI and viral shedding compared to unvaccinated controls. Although the study was not designed to compare the efficacy of the two vaccines, because of practical limitations on the number of animals and hence low power, there was no evidence of any significant differences between these two groups. There was, however, a trend towards slightly lower clinical score on days 4-8 and reduced virus excretion on days 2-5 in the Equilis Prequenza group compared to the HA canarypox vectored vaccine.”
MSD says Equilis Prequenza offers a broad based approach to immunogenicity by addressing and adapting key areas of an equine influenza vaccine - Matrix-C adjuvant, whole virus antigen and strain; efficacy has been proven through challenge trials and longer term protection confirmed by serology.
Vicki added: "Equilis Prequenza addresses key factors involved in promoting effective immunogenicity. It combines the demonstrated efficacy against challenge, with a current circulating strain with an established safety profile. Equilis Prequenza stimulates active immunity against EI providing the reassurance your clients demand. MSD Animal Health is committed to working with equine practices to improve vaccination rates in at-risk horses."
For more information about the trial results contact your MSD Animal Health account manager.
Martin Hosegood MRCVS has been selected to run for (your) Vetlife in the Virgin London Marathon.
Martin said: "Through my role at VDS where I assist those on the receiving end of an allegation of professional negligence or professional misconduct, I have seen the fantastic work that Vetlife does to assist anyone in the veterinary community who is having a difficult time. I’ve run the marathon before for other charities but there will be something special about running it to help support my own profession. I feel privileged to have been chosen."
Martin (aka Obed) is a Bristol graduate who worked mainly in large animal practice for 25 years before becoming a VDS claims consultant in 2010. He has also been advising a large safari park on the health, conservation and management of a wide range of zoo species for many years and still continues this role now, albeit in a reduced capacity.
Martin will be running on April 26th with 38,000 other runners – almost five times the number that ran the first race in 1981. Other competitors will include Tim Peake, who will be running the race aboard the International Space Station, Dame Kelly Holmes MBE, James Cracknell and Rosie Allister, Chair of Vetlife Helpline.
Rosie said: "It’s brilliant that Martin is giving up his time and training miles to support Vetlife. People who call Vetlife Helpline can often feel very alone; knowing the profession is behind us and wants to help can make a real difference. I’m hoping Martin waves as he overtakes me on the day! And that more vets and VNs will help us fundraise for Vetlife in the future."
Anyone willing to sponsor Martin can do so at: http://uk.virginmoneygiving.com/ObedMartinHosegood
Virbac has announced the launch of the Compulsory Chipping Support Pack, designed to help veterinary practices raise awareness of the importance of microchipping and the new legislation coming to England, Scotland and Wales in April.
The pack contains a range of promotional and educational items including:
Sarah Walker MRCVS, BackHome Product Manager, said: "Compulsory microchipping comes in this April and awareness needs to be raised among the general public – numerous reports in the media still show a significant proportion of dogs are not yet microchipped. The new BackHome Mini Chip has a 34% smaller needle than our standard needles and is ‘one size fits all animals’, making it easier than stocking different chips for different size pets.
"The resources in our Compulsory Microchipping Support Pack are great for practices to use. We want to help practices and the teams working within them to engage with the public in their vicinity and help to drive practice footfall."
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
References
Protexin has launched what is billed as the first therapeutic veterinary GI diet to contain an added probiotic: Pro-Balance, with Enterococcus faecium.
According to the company, dogs presenting the common clinical signs of upset, such as vomiting, diarrhoea, lack of appetite and weight loss are one of the most common reasons for a dog to be brought to the vets. The beneficial effect of probiotics on GI disorders by providing an influx of beneficial bacteria to the unbalanced gut has been extensively documented. As has the fact that, in acute cases, dogs respond well to dietary management following a short period of ‘gut rest', as an essential aid to a recovery programme recommended by the vet.
For more information, see: http://www.protexin.com/
Hill's Pet Nutrition has announced that it will not be exhibiting at the British Small Animal Veterinary Association Congress this year, and instead will be found in a restaurant round the corner called The Strada.
The press release containing this news fluttered in at almost exactly same time as one from the BSAVA, in which President Grant Petrie revealed that Congress already has a record-breaking exhibition.
Hill's' spin on the story is that it's all part of a new way of thinking about how the company does business. Blake Hawley, DVM and Managing Director at Hill's Pet Nutrition said: "It's easy to fall into the same old habits and routines. In fact, it can be enormously comforting to predict that in the year ahead, one will deliver, and probably receive, expected results. We don't think that's really quite good enough. So, we made the difficult and very conscious decision to question what we do and challenge how we think about the way we do business."
Hill's goes on to say that it will continue to support BSAVA and help provide a great experience for people attending the Congress, by offering free Italian food, coffee or a glass of beer or wine from its new restaurant location.
Some might call that supportive of BSAVA. Others, less generous, might call it a way of benefitting from all the work that the BSAVA does to bring everyone together at Congress without contributing towards the costs.
Thankfully, though, it doesn't look like BSAVA has been hit that hard by the news. Grant Petrie said: "BSAVA is a not-for-profit registered charity, and Congress is run by vets and nurses. So all of us - organisers, delegates and exhibitors - are supporting the veterinary profession simply by being involved. Together, we are officially part of a record breaking year - with 241 exhibitors in the NIA, along with our fellow associations in the ICC.
"That's more than we've ever had before, and there is a waiting list of companies wanting to join us at this flagship event. So every company who is seriously committed to vets and being involved in supporting the small animal veterinary profession will be with us in the NIA. BSAVA really appreciates the involvement of exhibitors in making Congress such a vital event in the veterinary calendar. It means that not only can we offer remarkably cost-effective CPD, but also provide a showcase of new advances in the industry and the opportunity to get the most from your practice budget. It is where budget holders get the best value, and where exhibitors can meet key decision makers.
"Plus, of course, there's a lot of fun and plenty of free gifts to be found in the NIA too!"
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Mr Smith was convicted of conspiracy to commit a fraud in which potentially dangerous horses were drugged and then sold to unsuspecting owners, at Maidstone Crown Court in June 2016. He was given 30 months' imprisonment, which formed one of the charges heard by the Disciplinary Committee.
There were also a number of charges related to his treatment of five different animals while in practice at the Lakeview Veterinary Centre in Folkestone, Kent. The charges were:
In relation to a Clydesdale mare named Grace on 14 August 2014 he failed to perform an adequate examination and/or undertake sufficient investigation and/or take a history of her; that after his initial visit to Grace on that day he failed to respond adequately to the owner’s telephone reports that Grace had deteriorated and/or failed to improve; and, that he failed to make adequate clinical records for Grace.
Between 29 September 2014 and 31 January 2015, in relation to a Labradoodle named Holly, he failed to keep adequate clinical records.
In relation to a cat named Maisey the allegations were that he failed to examine and investigate the cat adequately, he made a diagnosis of diabetes mellitus and gave insulin to administer to the cat without first undertaking the minimum investigation required, failed to keep adequate clinical records and sent an incorrect, misleading and dishonest statement to the RCVS regarding his treatment of Maisey. All charges date between 30 October and 19 December 2014.
In relation to a cat called Comet the allegation was that between 1 April and 17 April 2015 he failed to keep adequate clinical records and failed to respond adequately and appropriately to concerns raised by the owner.
Regarding a Yorkshire Terrier with diabetes named Poppy the allegation was that in two emergency out-of-hours calls made by Poppy’s owner to Mr Smith in April 2015 regarding the dog’s condition, he failed to recommend veterinary treatment or keep adequate clinical records. Furthermore, when the owner attended the practice following the two calls and the death of Poppy, he attributed the care to another member of the practice and failed to communicate effectively with the owner.
Having heard from a number of witnesses, including Mr Smith, and having received representations from Mr Smith in relation to the above charges, the Committee found almost all of the charges proven, with the exception of those relating to Mr Smith’s alleged conversation with Poppy’s owner at the practice following her death.
The Committee then went on to consider whether the various proven charges amounted to disgraceful conduct in a professional respect and whether the conviction rendered Mr Smith unfit to practise veterinary surgery.
In relation to the clinical charges the Committee found that, both individually and cumulatively, they amounted to disgraceful conduct in a professional respect.
The Committee also determined that the conviction rendered Mr Smith unfit to practise veterinary surgery and noted that it involved prolonged dishonesty, breach of trust, disregard for animal health and welfare and a "total abrogation of Mr Smith’s professional responsibilities."
Cerys Jones, chairing the Committee and speaking on its behalf, said: "The Committee was particularly concerned because the dishonesty went to the heart of Mr Smith’s responsibilities as a veterinary surgeon. His registration as a veterinary surgeon enabled him to take part in the conspiracy, and that role involved him conducting certified examinations on animals and supplying drugs for administration to animals. Reliable and honest certification is a vital element of the veterinary surgeon’s public role."
In considering the sanction against Mr Smith the Committee looked at the clinical charges and the conviction separately.
In relation to the clinical charges the Committee found that his treatment of the animals in these cases was fundamentally incompatible with being a veterinary surgeon. The Committee therefore directed that Mr Smith’s name should be removed from the Register of Veterinary Surgeons.
The Committee said that the case demonstrated that Mr Smith’s lack of treatment or his inappropriate treatment of these animals caused harm and that in some regards, for example the writing of accurate and contemporaneous clinical notes, Mr Smith demonstrated a total disrespect for the Code of Professional Conduct.
The Committee went on to say: "Further, he deliberately lied to his regulator. He demonstrated deep-seated attitudinal issues including a misplaced belief in his own abilities and had no insight or commitment to do anything different in the future. In those circumstances the likelihood of repetition was significant in the Committee’s view."
In considering the sanction for his conviction of conspiracy to commit fraud the Committee took into account a number of aggravating factors including the premeditated nature of the conduct, the fact it was repeated over four years and the fact that harm was caused to both animals and people as a result of his actions.
Cerys Jones said: "As the decision notes, some of the riders were novices or children and as a result of their experience they lost confidence in riding a horse. As the independent veterinary surgeon Mr Smith was in a position of responsibility because he was certifying the horses as to their suitability. A particularly aggravating feature in this case is that Mr Smith had previously been removed from the Register for falsely certifying horses for export."
In relation to the conviction the Committee also directed that the Registrar remove Mr Smith from the Register.
Mr Smith has 28 days from being informed of the Committee’s decision to make an appeal against it.
The full findings can be found here.
The Adaptil Diffuser has been renamed the Adaptil Calm Home Diffuser, the Adaptil Collar has been renamed Adaptil Calm On-the-Go Collar, Adaptil Spray is now called Adaptil Transport and Adaptil Tablets are now called Adaptil Express.
The new products are split into three colour-coded groups. In blue packaging, Adaptil Calm Home Diffuser is designed to help dogs stay calm in recurring situations at home, including staying alone, loud noises and visitors. It comes as a 30-day starter kit containing a diffuser and refill, and lasts for 30 days.
Adaptil Calm On-the-go Collar is for use when dogs face fearful situations outdoors. It is available in two collar sizes (small to fit necks up to 37.5cm and large to fit necks up to 62.5cm) and it lasts for four weeks.
Adaptil Transport comes in yellow packaging and is designed to make travel and visits to the vet less stressful. It is available in 60ml and 20ml bottles.
Adaptil Calm Home Diffuser, Adaptil Calm On-the-Go Collar and Adaptil Transport all contain dog appeasing pheremones to help dogs feel calm and relaxed.
The last product in the new range is Adaptil Express, which comes in green packaging. Adaptil Express is an oral supplement which Ceva says provides a fast, calming effect for dogs faced with occasional challenging events such as thunderstorms and fireworks. The non-pheromone tablets, which come in packs of 10 or 40 tablets, combine GABA and amino acids and can be given with or without food.
Abigail King, product manager for Adaptil, said: "80% of pet owners state that their dog gets stressed during challenging situations both inside and outside the home and during specific occasions such as travelling, fireworks and thunderstorms1. Adaptil’s new product range caters for all these eventualities and the eye-catching branding and packaging clearly indicates which product should be used for each challenging occasion to aid owner compliance and help dogs feel calm and relaxed at all times."
For further information, visit www.adaptil.com/uk.
Reference
The Royal College of Veterinary Surgeons (RCVS) has clarified the legal position regarding the disbudding of goats, following recent media reports concerning undercover filming on UK goat farms.
The carrying out of any activity which amounts to veterinary surgery is restricted to veterinary surgeons unless there is a suitable exemption that allows other people to do it. The removal of the horn-bud of goats (disbudding) is considered veterinary surgery under the provisions of the Veterinary Surgeons Act 1966 (the Act).
Schedule 3 of the Act provides certain exemptions to the restriction on carrying out veterinary surgery, such as those allowing veterinary nurses and student veterinary nurses to undertake any medical treatment or any minor surgery (not involving entry into a body cavity) in certain circumstances. However, Schedule 3 specifically provides that these exemptions do not allow non-veterinary surgeons to undertake the disbudding of goats, except the trimming of the insensitive tip of an in-growing horn which, if left untreated, could cause pain or distress.
There are no other Exemption Orders covering the disbudding of goats and therefore this procedure may only be undertaken by veterinary surgeons.
The Mutilations (Permitted Procedures) (England) Regulations 2007, the Mutilations (Permitted Procedures) (Wales) Regulations 2007 and the Prohibited Procedures on Protected Animals (Exemptions) (Scotland) Regulations 2007 all include disbudding of goats as a procedure which can be carried out for non-therapeutic reasons. However, this secondary legislation is subject to the restrictions in the Veterinary Surgeons Act 1966 and therefore disbudding of goats is restricted to veterinary surgeons.The Welfare of Animals (Permitted Procedures By Lay Persons) Regulations (Northern Ireland) 2012 currently include disbudding of goats as a procedure which may be carried out by non-veterinary surgeons. However, the Veterinary Surgeons Act 1966 applies to Northern Ireland and the Regulations are scheduled to be amended later in 2012. This will make it clear that only veterinary surgeons may disbud goats in the UK.
The secondary legislation in the UK does not explicitly require anaesthetic to be administered when disbudding goats. However, disbudding should be carried out by veterinary surgeons in accordance with good practice and in such a way as to minimise pain and suffering caused to the animal, which should include use of an anaesthetic.
In summary, only a veterinary surgeon may undertake the disbudding of goats and due to the nature of the procedure, veterinary surgeons disbudding goats should administer anaesthetic.
Virbac Animal Health has launched CaniLeish, the first vaccine for canine leishmaniosis in the European Union.
Leishmaniosis is a vector-borne parasitic disease caused by infection with protozoa of the genus Leishmania (L infantum in Europe). Leishmaniosis is transmitted by the bite of infected sandflies. In south-western Europe 2.5 million dogs are believed to be infected1,2 with the parasite and the disease is spreading northwards,3 as more people travel with their dogs or import infected animals from endemic areas.4 So far preventative methods have been limited to reducing the habitat of sandflies, minimising the physical contact of dogs with sandflies and using insecticides on dogs (sprays, spot-ons, repellent-collars, etc).
According to Virbac, CaniLeish's ability to protect dogs was demonstrated in an experimental challenge study, where the benefit of vaccination was still evident after one year.5 In an extreme condition natural challenge trial lasting two years under environmental conditions rarely encountered in reality, 93% of dogs vaccinated with CaniLeish did not develop symptomatic leishmaniosis. CaniLeish provides a fourfold reduction in the risk of developing this fatal disease. 6 Its safety profile has been shown in laboratory testing and field trials.7 In addition, Virbac says it contains no whole parasites that could be virulent in any host.
David McGahie BVMS Bsc (VetSci) MRCVS, Medical Department Manager at Virbac SA, said: "The development of this vaccine is a key milestone in the battle against this challenging disease which is a major problem in many regions of the world. Although in the past it was considered a rather exotic disease here in the UK, the advent of the Pet Travel Scheme means it has become increasingly important as a problem for dogs which regularly travel abroad to endemic regions."
CaniLeish can be given to dogs as young as six months of age: the primary course consists of three injections given over six weeks. Dogs should be re-vaccinated annually, with a single dose administered one year after the third injection and annually thereafter.
References:
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs. In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo - but due to the small number of dogs enrolled the results did not reach statistical significance. The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).> The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness-higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers' report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli. According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days' consecutive use, so owners can use it for a return journey the next day if need be. Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007- higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
Loseley, the ice-cream maker, has announced that it has developed a new way of making flavoured ice-cream by adapting the diet fed to its cows.
The first variety to be made using the new technique is 'Eton Mess', for which the company's herd is being fed a diet of strawberries and meringues.
Loseley says its cattle - which are housed at the Beechdean Dairies farm in Buckinghamshire - have already been feeding on the ingredients found in the much loved pudding for over a year, to ensure their milk supply is infused with the strawberry and meringue flavours. Apparently, huge amounts of strawberries are having to be air-freighted into the UK in order to ensure an uninterrupted supply through the seasons.Andrew Howard Managing Director of Beechdean Dairies said: "We have been perfecting the quantities in the cattle feed for over 18 months to perfect the Eton Mess flavour. The cows need to be fed just the right quantities of meringues, strawberries, fat and hay to make the perfect Eton Mess ice cream. We believe ice cream should be great quality, tasty and interesting. Our products will always deliver against these criteria."Vince Bamford, Fast Moving Consumer Goods Editor at The Grocer, the UK's leading grocery trade magazine said: "Loseley's flavour development process is cutting edge - I have tasted the product and it is delicious. It is an exciting innovation for the ice cream category."
The Animal Medicines Distributors Association (AHDA) and the Animal Medicines Training Regulatory Authority (AMTRA) have both come out against the BVA's call for all anthelmintic medicines to be reclassified as POM-V, which would prevent them being prescribed by Suitably Qualified Persons (SQP).
Ian Scott, Secretary General of AHDA, said that instead of launching an attack on SQPs, the BVA should be working with them and animal owners to tackle anthelmintic resistance: "The BVA has written to the VMD to ask that all anthemintics be classified to POM-V only. This will monopolise the supply and distribution of anthelmintics for vets only. It effectively places the blame for anthelmintic resistance squarely on SQPs.
"An attempt by BVA to create a division between vets and SQPs demonstrates that the BVA is out of touch with its members.
"Both prescribing channels must work together to tackle the problem and AHDA has been working hard with vets at national and local level to ensure customers receive consistent, high quality, up-to-date and relevant advice from both channels.
"What is worrying is that the BVA attack also infers that farmer producers and equine owners are incapable of making decisions that not only affect their livelihood but cast doubt on their ability to care for their animals' welfare."
Meanwhile, Stephen Dawson, Secretary General of AMTRA said: "The large majority of SQPs deal with parasite control on a daily basis, having trained and been examined to a syllabus developed with BVA input. SQPs have to undertake compulsory continuing professional development, the majority of which includes good practice in parasite control. Therefore AMTRA has every confidence that qualified SQPs have excellent knowledge of parasitology to advise their clients on the correct choice and use of anthelmintics.
"It is important to recognise the hard work, knowledge and dedication of thousands of SQPs throughout the UK. The implication of what BVA say is that they are laying a proportion of the blame for resistance to these medicines at the door of SQPs. But the evidence isn't there: countries in Europe and elsewhere with different prescription systems, mainly though vet-only channels, still have major resistance problems. Prescription of antimicrobials by veterinary surgeons hasn't prevented concerns about prescribing practices and developing resistance. The key point is good advice from the prescriber and how they are then used in practice, rather than who prescribes them. The challenge for us all is not just to seek excellence in prescribing but also in usage on farm, something SQPs are ideally placed to do with their frequent farmer contact.
"I would urge all parties to work in partnership to ensure that best practice in prescription and use is followed by all prescribers and users. It is up to all prescribers to act responsibly, but to single out one group over another is unjustified. A pseudo-monopoly by vets on supply would do nothing to help farmers in difficult times."
Mr Dawson also expressed doubts about permanent POM-V status for new livestock anthelmintics: "While we fully support VMD's and VPC's need to be sure that the risk associated with wider availability of a new product is low, AMTRA considers that the current division in distribution classes and consequent low uptake of the newer products means that the much bigger risk is that widespread reliance on the three aging classes may be followed by reliance on just the two new classes when the older classes become unusable. Much better to have responsible prescription of all five classes now, by appropriately trained SQPs, vets and pharmacists, to ensure that there is a prospect of long term availability of effective parasite control."
Some big names from the art and entertainment worlds, including Cheryl Cole, Tracey Emin, Twiggy and Jamie Oliver are donating their own paintings and drawings of hares to raise money for two new operating theatres at Great Ormond Street Hospital.
One of these A4 canvases would be a great addition to a veterinary practice waiting room. It would be sure to create an interesting talking point, particularly if you specialise in leporids.
If you're interested in buying one, they go under the auctioneer's hammer both online and at the 'Hare Ball' at the Dorchester Hotel in London on May 26th 2011.
The Hare Styling Celebrity Canvases Appeal is the brainchild of hairdresser Michael Van Clarke whose daughter Angelica was given a lifesaving operation at Great Ormond Street Hospital when she was just two days old. Now 15 years old, Angelica has drawn a hare to help raise funds for the hospital that saved her life. The hare has been reproduced on A4 canvases which have been sent to well-known names in the public eye inviting them to create an original artwork.
Other celebrities who have already donated include Stella McCartney, Tara Palmer-Tomkinson, Terry Venables and HRH Princess Beatrice The Duchess of York. Many more are expected ahead of the March deadline. All of the canvases will be displayed at a central London gallery exhibition and most will be included in a hard bound book printed to raise further money for Great Ormond Street Hospital Children’s Charity.
Michael Van Clarke said: “The pioneering work carried out at Great Ormond Street Hospital provides hope to extremely sick children and their families. My family knows first-hand the incredible difference the hospital can make and I am always looking for ways to show my gratitude. When we first came up with this Hare styling idea, we weren’t sure how it would be received, but we have been overwhelmed by the response from the recipients of the canvases.
"The fundraising potential of these canvases is huge and we are so grateful for the time and effort people have put in to creating them. We are also looking forward to handing over a big cheque to the charity once all the canvases have been sold.”
For further information or to see a selection of the canvases, please visit http://www.harestyling.com/.
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, is running an essay competition with a prize of an all-expenses-paid trip to the London Vet Show (London Olympia, 19th-20th November).
To win, you need to submit an essay of 1000 words or less which outlines an idea that will transform the veterinary/veterinary nursing profession by 2030. The College suggests that entrants might might look at a new business model, a new approach to education, a technological innovation or perhaps a way that the working lives of those in the practice team could be improved.
Anyone with an interest in the veterinary profession can enter the competition, including veterinary surgeons, nurses, practice managers and students.
The entries will be judged by the Vet Futures Project Board, which includes the Presidents and Chief Executives of both the Royal College of Veterinary Surgeons and the British Veterinary Association.
Entries will be anonymised then scored on a range of criteria, including originality, potential impact for the future and realistic prospects of change. The winning entry will be placed in a time capsule, to be opened by the veterinary profession in 2030.
The closing date for entries is midnight on Monday 31 August 2015, and the winner will be notified on Monday 7 September 2015.
The full rules and details of how entries can be submitted can be found on www.vetfutures.org.uk/essaycomp.
A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health.
In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.
Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.
Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".
The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.
The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.
In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.
Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.
*ReferenceSchmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651
The Bella Moss Foundation (BMF) has launched a free practice hygiene audit tool.
The BMF Practice Hygiene Self Audit is a web-based assessment tool that allows staff to monitor cleanliness across the practice – from theatre and prep rooms to laundry and waiting rooms.
The tick sheet format allows staff to rate the hygiene protocols in each area, resulting in a room-by-room percentage hygiene score, as well as an overall contamination risk score.
The tool was developed by vet and RCVS Practice Standards Scheme (PSS) expert Pam Mosedale and VN lecturer Louise O'Dwyer, along with Edinburgh academic Tim Nuttall and Chris Laurence.
Pam said: "Given the relaunch of the PSS later in the year, which will include new modules on infection control, the BMF audit tool is especially timely.
"We hope that people will try the audit tool and it will lead them to have more of a team discussion about hygiene routines and protocols in practice. We know some areas get more attention than others - for example, how often do things like the toys in the waiting area really get cleaned?
“By using the audit, staff will easily be able to see what rooms/areas might need a bit more cleaning.
She added: "It's a simple no-frills tool but the whole idea is for it to be helpful and easy to use, so more practices are encouraged to have regular quantifiable monitoring systems in place to keep an eye on their hygiene protocols."
Co-creator Louise O'Dwyer said: “The BMF Practice Hygiene Self Audit will help ensure often overlooked aspects of cleaning and infection control are considered and implemented.
“It needs to be embraced by all members of staff, from non-clinical staff through to veterinary surgeons, as every individual has the potential to make an impact within their practice by taking action on infection control.”
To test the tool and see how clean your practice is, go to: www.thebellamossfoundation.com/practice-hygiene-self-audit
A groundbreaking 3d printing service offered by Replica 3DM, a spin off of Salisbury NHS District Hospital, has helped referral veterinary orthopaedist Andy Moores in carrying out surgery on dog that won the 2013 Crufts Friends For Life Award.
Haatchi is an Anatolian shepherd dog whose back left leg and tail were amputated after he was tied to a railway line and hit by a train. As a rescue dog, he was adopted by the family of a young boy called Owen Howkins from Basingstoke. Owen has Schwartz‐Jampel syndrome, which causes his muscles to be permanently tense. The two bonded and became inseparable.
Earlier this year Haatchi developed mobility issues with his remaining hindlimb. He was referred to Anderson Moores Veterinary Specialists, in Hampshire, where a laterally luxating patella was diagnosed. The patella luxation was a result of a complex deformity of the femur and the tibia. Surgery was needed to enable Haatchi to use his leg better.
Replica 3DM, which normally uses its £70,000 printing equipment to make models of human bones and joints, created a 3d model of Haatchi’s hind leg from hip to paw. Normally the company charges around £200 for a human mandible. So, in order to keep costs down, it suggested a scaled down model which would still make Andy's preoperative planning a lot more straightforward and would help identify the correct surgical approach and likely abnormalities which would be encountered. Andy emailed the CT scans to Matt Sherry from Replica 3DM Ltd who converted them into a 3D model of Haatchi’s leg. Production of the model took six hours.
Andy said: "Having access to a scale 3D model of Haatchi's limb prior to surgery not only allowed us to better understand his deformity but it also allowed us to practice the femoral and tibial corrective osteotomies prior to surgery to be sure they would achieve what we intended."
Replica 3DM Ltd is based at Salisbury District Hospital and provides a service producing 3 dimensional products used in various types of surgery e.g. fractured neck of femur, cranioplasty procedures and jaw fractures. The company says that while of course not necessary in all procedures, visualisation of fractures and deformities prior to surgery can help in pre planning of surgery, reducing costs in time and equipment as well as enabling smaller incisions and less soft tissue intervention, so that patient recovery is enhanced.
For more information, visit www.replica3dm.com or ring Matt Sherry at Replica 3dm on 01722 429185.
The Kennel Club Genetics Centre at the Animal Health Trust has identified a genetic mutation which causes progressive retinal atrophy (PRA) in Golden Retrievers, and developed a DNA test to identify carriers.
PRA is a retinal disease which causes loss of vision and leads to blindness. PRA cannot be treated - the most successful way to combat the inherited condition is to identify dogs that carry the mutation and develop informed breeding strategies.
The new DNA test has been developed following the identification of the mutation which causes the most common form of PRA among Golden Retrievers in Europe - known as GR_PRA1. The mutation which causes a second form of PRA is still to be identified.
Cathryn Mellersh, Head of Canine Genetics at the AHT, said: "Our research shows that this mutation is present in the UK Golden Retriever population, so it's likely that several hundred new carriers are being born each year and that Golden Retrievers are invariably going blind as a result.
"This new DNA test will enable breeders to learn whether their dogs are carriers of the mutation. This, in turn, will enable them to make better informed breeding decisions and therefore produce puppies which will not go blind as a result of this mutation."
Mike Townsend, Chairman of the Kennel Club Charitable Trust, said: "This is a real breakthrough and one which we hope will help to prevent blindness in many Golden Retrievers in the years to come. Every dog deserves to lead a healthy, happy life and it is important that we do all we can to ensure that future generations are given this opportunity. Our knowledge about inherited diseases in dogs is growing every day and the development of DNA tests such as this one allows breeders to ensure that the healthiest genes are passed down through the generations."
The DNA test for PRA follows the success of the AHT's DNA test launched last year to identify carriers of a mutation that causes primary lens luxation. This test identifies carriers in more than 12 breeds of dog, including Miniature Bull Terriers, Jack Russell Terriers, Parson Russell Terriers and Patterdale Terriers. To date more than 6,500 samples from 36 countries have been tested.
The Kennel Club Charitable Trust has committed £1.2 million to the Kennel Club Genetics Centre at the AHT, which will undertake research into approximately 25 inherited diseases over the next five years, facilitating the creation of further diagnostic tests which will improve the health and welfare of generations of dogs.
Full information on the Golden Retrievers PRA DNA test, and information on ordering sample kits, will be available from http://www.aht.org.uk/ from 15 November.
An article by Consultant Biologist Clifford Warwick DipMedSci CBiol CSci EurProBiol FOCAE FSB in the current issue of the Journal of AWSELVA (the Animal Welfare Science, Ethics and Law Veterinary Association) is calling for greater scrutiny of the relationship between the veterinary profession and exotic pet trading.
The article, entitled 'Veterinary accountability and the exotic pet trade', was co-authored by biologist Catrina Steedman BSc(Hons) MSB and veterinary surgeon Emma Nicholas MA VetMB MRCVS
The authors accuse some vets of serving their own vested financial interests by directly aligning themselves with exotic pet trading. They say that these vets are effectively causing the wild-capture and intensive breeding, cramped storage, transport and sale of hundreds of thousands of fish, amphibians, reptiles and other animals.
The article points to scientific evidence showing that stress, disease and premature mortality commonly accompanies 'wild pets' at all stages of the trade and private keeping process.
The authors argue that promoting the trade in exotic animals runs counter to the veterinary profession's obligation to provide impartial guidance for the benefit of animal health and welfare, and that the issue of vets selling or promoting exotics in the home requires greater scrutiny for possible conflicts of interest and for contributing to harmful practices.
Lead author, Clifford Warwick DipMedSci CBiol CSci EurProBiol FOCAE FSB said: "By their nature, vets want to be and are obliged to be part of a solution to animal and human health and welfare matters. That a vet might have a hand in selling or promoting exotic pets is, in my view, tantamount to being part of a problem. And whether or not that represents a formal conflict of interest or questionable practice, I think the spotlight will continue focusing until there are no shaded areas."
He added: "In my view, the avoidance of unnecessary harm is a general responsibility we should all share, but I think veterinarians, like some other professionals, have a special responsibility in this regard. However, unnecessary harm is largely unavoidable with the exotic pet business. Whether wild-caught or captive-bred, animal suffering, species and environmental degradation, and public health concerns frequently go hand-in-hand with all stages of exotic pet trading and keeping practices."
Co-author Catrina Steedman BSc(Hons) MSB said: "Many vets are understandably critical of the exotic pet trade and its minefield of animal welfare, public health and environmental problems. It is unfortunate that a few vets, possibly with vested interests, feel it is appropriate to condone and even promote a trade that has such obvious negative consequences for animals and people."
Co-author, Emma Nicholas MA VetMB MRCVS said: "Vets have a responsibility to be approachable and impartial; animal welfare and also public health must be their priorities at all times. I believe it is pertinent that as a profession, we open the discussion as to how we best improve the welfare (health and quality of life) of existing exotic pets, and also educate and inform potential owners of "wild" or exotic animals of the associated welfare and public health considerations."
The article concludes that vets should '...occupy a detached position with no interest in the success or failure of the 'business' of exotic pet-keeping' and that 'any vet who recommends or endorses buying or keeping an exotic pet arguably imparts guidance that is not fully consistent with ensuring good animal welfare or human health'.
The charges were:
On 28 September 2015 she was convicted of stealing three packets of Tramadol to the value of £45 from Milton Keynes Veterinary Group.
On 20 April 2017 she was convicted on two counts of issuing a false prescription with the intention of being dispensed Tramadol.
On 15 June 2017 she was convicted of numerous counts of making false prescriptions, as well as stealing £108.47 worth of scratch cards and cigarettes from Premier Queensway Stores.
Between 5 January 2015 and 25 August 2015 she held herself out as a registered veterinary nurse when she was in fact not on the Register, and worked at two separate veterinary practices during that time; and that she was therefore either (i) being dishonest, or (ii) ought to have known that she was not registered.
That on or around 13 April 2016, she made a written representation on an application form for restoration to the Register that she had no criminal convictions, when on 28 September 2015 she had been convicted of burglary and that conviction was not spent; and that she was (i) either dishonest, or (ii) ought to have known that the representation was false.
Ms Wilde admitted charges 1-3, and the Committee were also provided with copies of the convictions. The Committee therefore found charges 1-3 proven.
In considering the fourth charge, they took into account Ms Wilde’s submission that she believed the submission of a cheque would be enough to restore her to the Register. The Committee noted that she had restored herself to the Register in the past, however, and so would have been aware that a cheque alone was not sufficient, and she had also been sent a restoration form following a telephone call with the College on 2 January 2015. The Committee therefore found that Ms Wilde was being dishonest, and determined that charge 4(i) was proven.
In considering the fifth charge, the Committee considered Ms Wilde’s submission that a Probation Officer had told her that her conviction was spent and that she need not declare it. The Committee believed this to be highly unlikely, however, especially as Ms Wilde had provided no evidence from the probation service to support this assertion. The Committee therefore found her to be dishonest, and charge 5(i) to be proven.
The question of whether the facts amounted to serious professional misconduct was, however, solely a matter for the Committee’s judgement. It determined that Ms Wilde’s conduct in relation to charges 1-3 had fallen far short of the standard expected of an RVN and her conduct clearly renders her unfit to practise as an RVN.
Similarly, the Committee found that Ms Wilde’s conduct had fallen far short of the standard expected of an RVN in respect of charges 4-5, and found her conduct clearly amounted to disgraceful conduct in a professional respect.
The Committee then turned to the question of sanction, firstly in respect of charges 1-3. It considered some testimonials that spoke on Ms Wilde’s behalf, but noted that they were all unsigned and none made any reference to the charges against her. The Committee also bore in mind that Ms Wilde had no previous disciplinary history and was apologetic and remorseful, and that no harm had come to animals or humans by her actions.
It also considered, however, that her behaviour had been repeated and sustained, that she had used her knowledge as an RVN to forge prescriptions, and that she had breached the trust of her employers by stealing from them. The Committee therefore decided that removal from the Register was the only appropriate sanction.
When considering sanction in respect of charges 4-5, the Committee took into account that Ms Wilde had difficult personal circumstances and was sincerely apologetic. Using her title of RVN to gain employment when she was not on the Register, however, and breaching the trust of the College by making a false declaration, were considered serious aggravating features. It therefore considered that removal from the Register was again the only appropriate sanction.
Judith Way, who chaired the Committee and spoke on its behalf, said: “Ms Wilde’s criminal behaviour failed to maintain public confidence in the veterinary nursing profession and it failed to declare and uphold proper standards of conduct and behaviour.
“She also knew that she was not registered as an RVN, yet she held herself out as being so and obtained employment in that capacity. In holding herself out in this manner she potentially put her colleagues at risk. She could have compromised the practices that employed her in the capacity of an RVN as their insurance had the potential to be invalidated.
“Ms Wilde was also dishonest with the RCVS when she completed the application for restoration of registered veterinary nurses’ form by stating that she had no convictions. Following this application, Ms Wilde went on to commit the seven further offences (from December 2016 to March 2017) for which she was later convicted in the Northampton and Leicester Magistrates’ Courts. The committee considered that such conduct falls far short of the standards expected of an RVN.”
Ms Wilde may appeal the Committee’s decision within 28 days of being informed of it. If no appeal is received, the Committee’s judgment takes effect.
Supreme Petfoods is calling on veterinary surgeons and nurses to take part in its 'Think Rabbit Month' campaign coming up in May.
The campaign is designed to attract more rabbit and guinea pig owners into practices.
Over 500 UK vet practices took part in the campaign last year and, according to the company, many used the opportunity to raise awareness about their rabbit healthcare services, such as dental checks and vaccination programs.
In the run up to Think Rabbit Month, Supreme has published the 'Think Rabbit Virtual Manual', a guide which shows how to make veterinary practices more rabbit friendly. It is now free to download from Supreme's website. In addition, there are a range of goodie bag giveaways, money off vouchers, care guides and food samples for clients, together with educational material to promote best practice care.
Participating practices can display the Think Rabbit 'Small Furry Promise' certificate, posters for the waiting room and can register for the 'Happy Hoppers Club' - a scheme that brings vets and pet owners together to promote small furry welfare.
The event is backed by RCVS Exotics Specialist, Molly Varga who said: "I'd encourage all vet practices to take part in Think Rabbit Month this May to help improve the health and welfare of the nation's rabbits and guinea pigs."
Vets and nurses are also being encouraged to help promote the national 'Rabbit Habits' survey to learn more about how owners care for their pets. The results will be shared with the profession in due course.
For more information, visit: http://www.supremepetfoods.com/think-rabbit/